PsyAccess
Am I eligible?
Am I eligible?
Clinical trialsRegistry-verifiedDesignated-centers model

University Of Brescia

Brescia, Italy

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeTrial
  • Cost & coverage (registry status)Free within clinical trial
  • Websitehttps://www.unibs.it

About this provider

Compiled from the registry data on this page.

This entry describes a clinical trial site: University Of Brescia, Brescia, Italy. The site takes part in CTIS trial 2023-506617-21-00, a randomised controlled trial of a six-week intensified pharmacological treatment for major depressive disorder, compared to treatment as usual, after a first-time failure of first-line treatment (sponsor: Universitair Medisch Centrum Utrecht). The treatment studied is esketamine (Spravato); access runs through enrolment in the trial, and participation is free of charge within it. The CTIS public record in the EU Clinical Trials Information System is the registry source cited. Last verification of this entry: 2026-08-01.

Verification

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to University Of Brescia, with your consent.

What to prepare before you enquire

  • A referral or the contact details of your treating clinician
  • A list of medications you have tried (names, doses, duration)
  • A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire